Shengming Xu

Analysis of Mucosal Melanoma Whole-Genome Landscapes Reveals Clinically Relevant Genomic Aberrations

Rong Zhou, Chaoji Shi, Wenjie Tao et al. · Clinical Cancer Research · 2019 · 128 citations · Full text

Medicine, Genetics, Oncology +17

NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC

Wenjie Tao, Guocai Tian, Shengming Xu et al. · Cancer Cell International · 2021 · 86 citations · Full text

Medicine, Molecular Biology, Oncology +17

EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy

Shuli Liu, Yang Wang, Yong Han et al. · Theranostics · 2020 · 43 citations · Full text

Medicine, Cancer Biology, Oncology +15

Targeting LSD1 suppresses stem cell-like properties and sensitizes head and neck squamous cell carcinoma to PD-1 blockade

Yong Han, Shengming Xu, Weimin Ye et al. · Cell Death and Disease · 2021 · 41 citations · Full text

Medicine, Cancer Biology, Oncology +17

Candidate therapeutic agents in a newly established triple wild‐type mucosal melanoma cell line

Chaoji Shi, Ziyue Gu, Shengming Xu et al. · Cancer Communications · 2022 · 23 citations · Full text

Medicine, Genetics, Oncology +17